Melissa K. Carpenter

Chief Scientific Officer of Regenerative Medicine at ElevateBio LLC

Melissa K. Carpenter

Melissa K. Carpenter

Chief Scientific Officer of Regenerative Medicine at ElevateBio LLC

Overview
RelSci Relationships

155

Number of Boards

1

Relationships
RelSci Relationships are individuals Melissa K. Carpenter likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Histogen, Inc.

Relationship likelihood: Strong

Managing Partner & Founder at Proteus RM LLC (Venture Capital)

Relationship likelihood: Strong

Former Chief Scientific Officer & Vice President at ViaCyte, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Innovate UK

Relationship likelihood: Average

Founder, President & Chief Executive Officer at Avrobio, Inc.

Relationship likelihood: Average

Director, Technology Licensing Office at Massachusetts Institute of Technology

Relationship likelihood: Average

Fund Advisor at City Financial Investment Co., Ltd.

Relationship likelihood: Average

President, Chief Executive Officer & Director at Centre for Commercialization of Regenerative Medicine

Relationship likelihood: Average

Vice President, Research & Innovation at University of Toronto

Relationship likelihood: Average

Professor at University of Toronto

Relationship likelihood: Average

Paths to Melissa K. Carpenter
Potential Connections via
Relationship Science
You
Melissa K. Carpenter
Chief Scientific Officer of Regenerative Medicine at ElevateBio LLC
Education

University of California, Irvine is a public research university located in Irvine, California and one of the 10 general campuses in the University of California (UC) system. UCI's Orange County campus is the fifth-largest in the UC system. UC Irvine is considered a Public Ivy and became a member of the Association of American Universities in 1996, and is the youngest university to hold membership. It also administers the UC Irvine Medical Center, a large teaching hospital; the UC Irvine Health Sciences system in the City of Orange; the University of California, Irvine, Arboretum; and a portion of the University of California Natural Reserve System.

Career History
Director-Stem Cell Biology
Prior

Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.

Senior Scientific Advisor
Prior

Proteus Venture Partners (PVP) focuses on investments in market-leading, private companies operating in the field of regenerative medicine. The firm invests primarily in the following areas: (1) cell therapy (2) tissue engineering (3) medical tools and Devices and (4) aesthetic medicines. PVP is stage agnostic and invests in companies located across a diverse range of geographic locations.

Vice President-Research & Development
2006 - Prior

ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA.

Boards & Committees
Member, Board of Directors
Prior

Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Melissa K. Carpenter. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Melissa K. Carpenter's profile does not indicate a business or promotional relationship of any kind between RelSci and Melissa K. Carpenter.